This Version 3. 1 Addendum to the Cybernetic Hematopoiesis framework bridges the theoretical architecture of the MetaboJoint Vault with the exact macromolecular physics and bioinformatics required for in vivo wet-lab translation, aimed at the conditioning-free eradication of Sickle Cell Disease (SCD). Critically, this update resolves the "Steric Trap" by decoupling the bistable Duffing oscillator snap-through from the Lustig-Peppas diffusion phase, mathematically proving that post-enzymatic cleavage, the polymer mesh size expands (ξₑff ≈ 12. 0 nm) to physically accommodate the 9. 0 nm Cas9 RNP payload and ensure controlled Fickian elution (Dg/D₀ ≈ 0. 20). Furthermore, it optimizes payload bioinformatics by restoring Path A (Adenine Base Editing via ABE8e) for direct HBB c. 20A>T correction and geometrically calibrating Path B to guarantee a mathematically clean blast radius. To support physical synthesis, the addendum locks the RAFT polymerization stoichiometry to maintain the strict 70: 30 SBMA: CBMA mass ratio required for systemic bistability (terminating at a 37. 4 kDa final construct) and defines four critical translational engineering constraints, including a new 48-hour circulatory stability assay. Released into the public domain as prior art, this document transitions the MetaboJoint AND gate from a computational blueprint into a fully parameterized, falsifiable laboratory specification, serving as a direct call for collaboration within the stimuli-responsive biomaterials and targeted nanoparticle delivery communities.
Don Feeney (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: